by American Academy of Neurology Credit: Sasha Wolff/WikipediaMigraine is often under-diagnosed and untreated, and even when it is treated, it can be difficult to treat early enough as well as find strategies to prevent attacks. A new study looks at ways to more accurately predict when a migraine will occur—through the use of mobile apps to...
(HealthDay)—Compared with placebo, treatment with intravenous eptinezumab after the onset of a moderate-to-severe migraine attack shortens time to resolution of headache pain and the most bothersome symptom, according to a study published in the June 15 issue of the Journal of the American Medical Association. In phase 3, randomized, placebo-controlled trial, Paul K. Winner, D.O.,...
